Translating	B:C3161035
Neurocognitive	I:C3161035
Models	I:C3161035
of	O
Auditory	B:C0424068
-	I:C0424068
Verbal	I:C0424068
Hallucinations	I:C0424068
into	O
Therapy	O
:	O
Using	O
Real	O
-	O
time	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
-	O
Neurofeedback	B:C2713543
to	O
Treat	O
Voices	B:C0042939
.	O

Auditory	B:C0424068
-	I:C0424068
verbal	I:C0424068
hallucinations	I:C0424068
(	O
Auditory	B:C0424068
-	I:C0424068
verbal	I:C0424068
hallucinations	I:C0424068
)	O
are	O
frequent	O
and	O
disabling	O
symptoms	B:C1457887
,	O
which	O
can	O
be	O
refractory	O
to	O
conventional	O
psychopharmacological	O
treatment	O
in	O
more	O
than	O
25	O
%	O
of	O
the	O
cases	O
.	O

Recent	O
advances	O
in	O
brain	B:C0203860
imaging	I:C0203860
allow	O
for	O
a	O
better	O
understanding	O
of	O
the	O
neural	O
underpinnings	O
of	O
Auditory	B:C0424068
-	I:C0424068
verbal	I:C0424068
hallucinations	I:C0424068
.	O

These	O
findings	O
strengthened	O
transdiagnostic	B:C3161035
neurocognitive	I:C3161035
models	I:C3161035
that	O
characterize	O
these	O
frequent	O
and	O
disabling	O
experiences	O
.	O

At	O
the	O
same	O
time	O
,	O
technical	O
improvements	O
in	O
real	O
-	O
time	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
(	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
)	O
enabled	O
the	O
development	O
of	O
innovative	O
and	O
non-invasive	O
methods	O
with	O
the	O
potential	O
to	O
relieve	O
psychiatric	B:C0233401
symptoms	I:C0233401
,	O
such	O
as	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
-	O
based	O
neurofeedback	B:C2713543
(	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
-	O
NF	B:C2713543
)	O
.	O

During	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
-	O
NF	B:C2713543
,	O
brain	B:C0443158
activity	I:C0443158
is	O
measured	O
and	O
fed	O
back	O
in	O
real	O
time	O
to	O
the	O
participant	B:C0679646
in	O
order	O
to	O
help	O
subjects	B:C0080105
to	O
progressively	O
achieve	O
voluntary	O
control	O
over	O
their	O
own	O
neural	B:C0443158
activity	I:C0443158
.	O

Precisely	O
defining	O
the	O
target	O
brain	B:C0005898
area	I:C0005898
/	O
network	O
(s	O
)	O
appears	O
critical	O
in	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
-	O
NF	B:C2713543
protocols	B:C0542547
.	O

After	O
reviewing	O
the	O
available	O
neurocognitive	B:C3161035
models	I:C3161035
for	O
Auditory	B:C0424068
-	I:C0424068
verbal	I:C0424068
hallucinations	I:C0424068
,	O
we	O
elaborate	O
on	O
how	O
recent	O
findings	B:C0243095
in	O
the	O
field	O
may	O
help	O
to	O
develop	O
strong	O
a	O
priori	O
strategies	O
for	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
-	O
NF	B:C2713543
target	O
localization	O
.	O

The	O
first	O
approach	O
relies	O
on	O
imaging	B:C0011923
-	O
based	O
"	O
trait	O
markers	B:C0005516
"	O
(	O
i.e.	O
,	O
persistent	O
traits	O
or	O
vulnerability	O
markers	B:C0005516
that	O
can	O
also	O
be	O
detected	O
in	O
the	O
presymptomatic	B:C2936329
and	O
remitted	O
phases	O
of	O
Auditory	B:C0424068
-	I:C0424068
verbal	I:C0424068
hallucinations	I:C0424068
)	O
.	O

The	O
goal	B:C0018017
of	O
such	O
strategies	O
is	O
to	O
target	O
areas	B:C0205146
that	O
show	O
aberrant	O
activations	O
during	O
Auditory	B:C0424068
-	I:C0424068
verbal	I:C0424068
hallucinations	I:C0424068
or	O
are	O
known	O
to	O
be	O
involved	O
in	O
compensatory	O
activation	O
(	O
or	O
resilience	O
processes	O
)	O
.	O

Brain	B:C1273723
regions	I:C1273723
,	O
from	O
which	O
the	O
NF	B:C2713543
signal	O
is	O
derived	O
,	O
can	O
be	O
based	O
on	O
structural	B:C0376335
MRI	I:C0376335
and	O
neurocognitive	B:C0518895
knowledge	I:C0518895
,	O
or	O
functional	B:C0376335
MRI	I:C0376335
information	O
collected	O
during	O
specific	O
cognitive	O
tasks	O
.	O

Because	O
hallucinations	B:C0018524
are	O
acute	O
and	O
intrusive	O
symptoms	B:C1457887
,	O
a	O
second	O
strategy	O
focuses	O
more	O
on	O
"	O
state	B:C0005516
markers	I:C0005516
.	O
"	O

In	O
this	O
case	O
,	O
the	O
signal	O
of	O
interest	O
relies	O
on	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
capture	O
of	O
the	O
neural	B:C0242406
networks	I:C0242406
exhibiting	O
increased	O
activity	O
during	O
Auditory	B:C0424068
-	I:C0424068
verbal	I:C0424068
hallucinations	I:C0424068
occurrences	O
,	O
by	O
means	O
of	O
multivariate	O
pattern	O
recognition	O
methods	O
.	O

The	O
fine	O
-	O
grained	O
activity	B:C0449774
patterns	I:C0449774
concomitant	O
to	O
hallucinations	B:C0018524
can	O
then	O
be	O
fed	O
back	O
to	O
the	O
patients	O
for	O
therapeutic	O
purpose	O
.	O

Considering	O
the	O
potential	O
cost	O
necessary	O
to	O
implement	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
-	O
NF	B:C2713543
,	O
proof	O
-	O
of	O
-	O
concept	O
studies	B:C2603343
are	O
urgently	O
required	O
to	O
define	O
the	O
optimal	O
strategy	O
for	O
application	O
in	O
patients	O
with	O
Auditory	B:C0424068
-	I:C0424068
verbal	I:C0424068
hallucinations	I:C0424068
.	O

This	O
technique	O
has	O
the	O
potential	O
to	O
establish	O
a	O
new	O
brain	B:C0203860
imaging	I:C0203860
-	O
guided	O
psychotherapy	B:C0033968
for	O
patients	O
that	O
do	O
not	O
respond	O
to	O
conventional	O
treatments	O
and	O
take	O
functional	B:C3178877
neuroimaging	I:C3178877
to	O
therapeutic	O
applications	B:C0185125
.	O

